Skip to main content
. 2017 Jul 19;28(10):3076–3088. doi: 10.1681/ASN.2016050598

Table 1.

Baseline characteristics of the HFM Study Cohort and subgroups with full cross-sections, partial cross-sections, and no vein specimen available

Factor All Study Participants (n=602) Participants with Full Cross-Section (n=371) Participants with Partial Cross-Section (n=183) Participants without Vein Specimen (n=48)
Age at time of surgery, years 55.2±13.4 55.6±13.8 54.7±13.1 53.1±11.2
Female 179 (29.7) 112 (30.2) 53 (29.0) 14 (29.2)
Blacka 264 (44.4) 155 (42.5) 85 (47.0) 24 (50.0)
Years of prior dialysis (hemo or peritoneal) 0.96±2.20 0.94±2.23 1.13±2.34 0.46±1.17
Diabetes prevalence 353 (58.6) 223 (60.1) 105 (57.4) 25 (52.1)
Cardiovascular diseaseb 315 (52.3) 202 (54.5) 93 (50.8) 20 (41.7)
Coronary artery diseasec 156 (25.9) 106 (28.6) 43 (23.5) 7 (14.6)
Cerebrovascular diseased 88 (14.6) 54 (14.6) 24 (13.1) 10 (20.8)
Venous thromboembolic diseasee 37 (6.1) 23 (6.2) 11 (6.0) 3 (6.3)
Peripheral arterial diseasef 91 (15.1) 54 (14.6) 32 (17.5) 5 (10.4)
Body mass index, kg/m2 30.38±7.57 30.44±7.84 30.24±7.13 30.51±7.09
Tobacco use (current, former)a 325 (54.4) 212 (57.5) 92 (50.5) 21 (45.7)
On dialysis (HD or PD) at time of surgery 387 (64.3) 235 (63.3) 125 (68.3) 27 (56.3)
Fistula location: upper arm 459 (76.2) 281 (75.7) 146 (79.8) 32 (66.7)
Draining vein
 Basilic vein 172 (28.6) 130 (35.0) 32 (17.5) 10 (20.8)
 Cephalic vein 418 (69.4) 236 (63.6) 145 (79.2) 37 (77.1)
 Brachial vein 12 (2.0) 5 (1.3) 6 (3.3) 1 (2.1)

Data are displayed as count (%) or, for quantitative variables, mean ± SD. HD, hemodialysis; PD, peritoneal dialysis.

a

Race is not reported for eight participants. Tobacco use is not reported for five participants. Percent is calculated out of available data.

b

History of any of the following: myocardial infarction, angina, coronary artery bypass surgery or angioplasty, congestive heart failure, cardiac arrhythmias or conduction problems, stroke, transient ischemic attack, carotid endarterectomy, carotid artery angioplasty, claudication, lower extremity arterial bypass surgery or angioplasty, and nontraumatic amputation.

c

History of any of the following: angina, coronary artery angioplasty or bypass, or myocardial infarction.

d

History of any of the following: stroke, transient ischemic attack, carotid endarterectomy, or carotid angioplasty.

e

History of any of the following: deep venous thrombosis, or pulmonary embolism.

f

History of any of the following: claudication, lower extremity angioplasty or bypass surgery, or nontraumatic amputation.